Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: Isotype restriction and polyclonality

Diabetes Care

Volumn 23, Issue 2, 2000, Pages 228-233

  Hawa, Mohammed I ^a   Fava, Danila ^b   Medici, Francesco ^a   Deng, Yang Jia ^c   Notkins, Abner L ^c   De Mattia, Giancarlo ^b   Leslie, R David G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; IA ANTIBODY; IMMUNOGLOBULIN G1; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; STIFF MAN SYNDROME;

EID: 0033985729     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.2.228     Document Type: Article

References (28)

1. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RD: Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 41:782-787, 1997
2. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 42:3-14, 1999
3. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chan HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
4. Lan MS, Wasserfall C, Maclaren NK, Notkins AL: IA-2, a transmembrane protein of the protein lyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 93:6367-6370, 1996
5. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dryberg T, Akerblom HK, Knip M: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. J Clin Invest 101:527-336, 1998
6. Tuomi T, Carlsson Å, Li H, Isomaa A, Miettinen A, Nissén M, Ehrnström B-J, Forsén B, Snickars B, Lahti K, Forsblom G, Saloranta G, Taskinen M-R, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
7. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decaboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350: 1288-1293, 1997
8. Solimena M, Folli F, Dennis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM: Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type 1 diabetes mellitus. N Engl J Med 318:1012-1020, 1988
9. Millward BA, Hussain MJ, Peakman M, Pyke DA, Leslie RDG, Vergani D: Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgGI subclass restriction and polyclonality. Clin Exp Immunol 71:353-356, 1988
10. Dozio N, Belloni C, Girardi AM, Genovese S, Sodoyez JG, Bottazzo GF, Pozza G, Bosi E: Heterogenous IgG subclass distribution of isle: cell antibodies. J. Autoimmun 7:45-53, 1944
11. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 381:787-793, 1996
12. Toellner KM, Luther SA, Sze DMY, Choy RKW, Taylor DR, Maclennan ICM, Acha-Orbea H: T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp Med 187:1193-1204, 1998
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
14. Schmidli RS, Colman PG, Bonifacio E, participating laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 44: 636-640, 1995
15. Jefferies R, Reimer CB, Skvaril F, de Lange G, Ling NR, Lowe J, Walker MR, Phillips DJ, Aloisio CH, Wells TW, Vaerman JP, Magnusson CJ, Kubagawa H, Cooper M, Vartdal F, Vandvik B, Haaijman JJ, Makela O, Sarnesto A, Lando Z, Gergeley J, Rajravolgyi E, Laszlo G, Radl J, Molinaro GA: Evaluation of monoclonal antibodies having specificity for human IgG subclass: results of an IUIS/WHO collaborative study. Immunol Lett 10:253, 1985
16. Updyke TV, Nicolson GI: Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices. J Immunol Methods 73:83-95, 1984
17. Hawa MI, Lohmann T, Leslie RDG, Londei M: Distinct immune reactivity to GAD65 in stiff man syndrome and type 1 diabetes (Abstract) Diabetologia 41:A93, 1998
18. Couper JJ, Harrison LC, Aldis JJ, Colman PG, Honeyman MC, Ferrante A: IgG subclass antibodies to glutamic acid decarboxylase and risk lor progression to clinical insulin-dependent diabetes. Hum Immunol 59:493-499, 1998
19. Esnault VL, Jayne DR, Weetman AP, Lockwood CM: IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up. Immunology 74:714-718, 1991
20. Madec AM, Rousset F, Ho S, Robert F, Thivolet C, Orgiazzi J, Lebecque S: Lour IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase. J Immunol 156:3541-3549, 1996
21. Tremble J, Morgenthaler NG, Vlug A, Powers AC, Christie MR, Scherbaum WA, Banja JP: Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J Clin Endocrinol Metab 82:2664-2670, 1997
22. Petersen JS, Kulmala P, Clausen JT, Knip M, Dyerberg T: Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65). Childhood Diabetes in Finland Study Group. Clin Immunol 90:276-281, 1999
23. Bonifacio E, Scirpoli M, Kredel K, Fuchtenbusch M, Zeigler AG: Early autoantibody responses in prediabetes arc IgGI dominated and suggest antigen-specific regulation. J Immunol 163:525-532, 1999
24. Ng WY, Thai AC, Lui KF, Yeo PP, Cheah JS: Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients. Diabetes Res Clin Pract 43: 127-135, 1999
25. Hutchings P, Tonks P, Cooke A: Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes 46:779-784, 1997
26. Leslie RDG, Pozzilli P: Type 1 diabetes masquerading as type 2 diabetes. Diabetes Care 17:1214-1219, 1994
27. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ: GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 18:1557-1565, 1995
28. Seissler J, De Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA: Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 41:891-897, 1998